Corrections to Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: A double-blind, randomised, placebo-controlled trial with an open-label extension [Lancet Neurol, (2013)]

摘要

Trenkwalder C, Benes H, Grote L, et al Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension Lancet Neurol 2013; published online Oct 18. http.7/dx.doi.org/10.10l6/S1474-4422(13,)70239-4-In paragraph 8 of the Results section, the findings for constipation should have read "12 (8%) of 150 patients had clinically relevant constipation as an adverse event during the double-blind phase." This correction has been made to the online version as of Oct 23, 2013, and will be made to the printed Article.